4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow Hemoglobinuria: new trials by email Literature Review of Hemoglobinuria trials Research Report on Hemoglobinuria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase IIa Study to Assess the Safety, Efficacy, and Pharmacokinetics of Subcutaneously Administered Pegcetacoplan (APL-2) in Subjects With PNH Pegcetacoplan - PNH | Phase 2 | Completed | Apellis Pharmaceuticals, Inc. | 4 | 2018-08-16 | 2020-12-22 |
| A Long-Term Treatment Study of ACH-0144471 in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) ACH-0144471 - Paroxysmal Nocturnal Hemoglobinuria | Phase 2 | Completed | Alexion Pharmaceuticals, Inc. | 8 | 2017-06-22 | 2023-03-14 |
| Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Danicopan - Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 2 | Completed | Alexion Pharmaceuticals, Inc. | 10 | 2017-03-31 | 2022-06-23 |
| Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies CliniMACS, Stem cell transplantation, Fludarabine - Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML) | Phase 2 | Completed | St. Jude Children's Research Hospital | 73 | 2007-12-14 | 2020-04-14 |
Hemoglobinuria, Paroxysmal (4) · Anemia (1) · Hematologic Diseases (1) · Hemolysis (1) · Hodgkin Disease (1) · Leukemia (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myelomonocytic, Juvenile (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Myelodysplastic Syndromes (1)
Anemia, Hemolytic (4) · Bone Marrow Diseases (4) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Hemic and Lymphatic Diseases (4) · Male Urogenital Diseases (4) · Pathological Conditions, Signs and Symptoms (4) · Proteinuria (4) · Signs and Symptoms (4) · Urination Disorders (4) · Urogenital Diseases (4) · Urologic Diseases (4) · Urological Manifestations (4) · Anemia (3) · Hematologic Diseases (3)
danicopan (2) · Alemtuzumab (1) · Antilymphocyte Serum (1) · Cyclophosphamide (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Melphalan (1) · Muromonab-CD3 (1) · Mycophenolic Acid (1) · Rituximab (1) · Stem Cell Transplantation (1) · Thiotepa (1) · fludarabine (1) · fludarabine phosphate (1) · pegcetacoplan (1)
Alexion Pharmaceuticals, Inc. (2) · Apellis Pharmaceuticals, Inc. (1) · St. Jude Children's Research Hospital (1)
Italy (2) · New Zealand (2) · South Korea (2) · Bulgaria (1) · Serbia (1) · United Kingdom (1) · United States (1)
Brandon Triplett, MD (1) · Federico Grossi, MD, PhD (1)
PMID 33121236, PMID 35869170, PMID 41124654
2016 (1), 2017 (1)